Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v20-FR | Version v13-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-02-06 | 2025-01-09 |
| Drug Identification Number | 02130181 | 02130181 |
| Brand name | PROLEUKIN | PROLEUKIN |
| Common or Proper name | PROLEUKIN | PROLEUKIN |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | ALDESLEUKIN | ALDESLEUKIN |
| Strength(s) | 22000000UNIT | 22000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1 VIAL | 1 VIAL |
| ATC code | L03AC | L03AC |
| ATC description | IMMUNOSTIMULANTS | IMMUNOSTIMULANTS |
| Reason for shortage | Other (Please describe in comments) | Delay in shipping of the drug. |
| Anticipated start date | 2024-09-13 | 2024-09-13 |
| Actual start date | ||
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | Yes | Yes |
| Company comments | Imported product is available to meet demand. | Product is on allocation at 100% at wholesaler. Current inventory is expiring February 28th, 2025. |
| Health Canada comments |